167
Views
14
CrossRef citations to date
0
Altmetric
Original Article: Clinical

[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy

, , , , & , M.D.
Pages 904-911 | Received 28 Jan 2009, Accepted 23 Mar 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nicolas Aide, Louis Irving & Rodney J. Hicks. (2009) Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier. Leukemia & Lymphoma 50:6, pages 865-867.
Read now

Articles from other publishers (13)

Annelieke E. C. A. B. Willemsen, Jolien Tol, Nielka P. van Erp, Marianne A. Jonker, Maaike de Boer, Bob Meek, Paul C. de Jong, Coline van Moorsel, Winald R. Gerritsen, Jan C. Grutters & Carla M. L. van Herpen. (2019) Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane. Targeted Oncology 14:4, pages 441-451.
Crossref
Kimberly Keefer, Regis Bender, Jason Liao, Jeffrey Sivik & Andry Van de Louw. (2018) Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival. Annals of Hematology 97:12, pages 2373-2380.
Crossref
Hossein Jadvar. (2017) The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity. Diagnostics 7:3, pages 43.
Crossref
Vickie R. Shannon, George A. Eapen, Carlos A. Jimenez, Horiana B. Grosu, Rodolfo C. Morice, Lara Bashoura, Scott E. Evans, Roberto Adachi, Michael Kroll, Saadia A. Faiz, Diwakar D. Balachandran, Selvaraj E. Pravinkumar & Burton F. Dickey. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 29 .
Sameer Kamalakar Taywade, Rakesh Kumar, Sainath Bhethanabhotla & Chandrasekhar Bal. (2015) Role of 18F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer — 2 Case Reports. Nuclear Medicine and Molecular Imaging 50:3, pages 261-265.
Crossref
P. Calvillo Batllés, J. Carreres Polo, J. Sanz Caballer, M. Salavert Lletí & L. Compte Torrero. (2015) Hematologic neoplasms: Interpreting lung findings in chest computed tomography. Radiología (English Edition) 57:6, pages 455-470.
Crossref
P. Calvillo Batllés, J. Carreres Polo, J. Sanz Caballer, M. Salavert Lletí & L. Compte Torrero. (2015) Neoplasias hematológicas: interpretación de los hallazgos pulmonares en la tomografía computarizada torácica. Radiología 57:6, pages 455-470.
Crossref
Claudia Omarini, Eirini Thanopoulou & Stephen R. D. Johnston. (2014) Pneumonitis and pulmonary fibrosis associated with breast cancer treatments. Breast Cancer Research and Treatment 146:2, pages 245-258.
Crossref
A. V. Hadjinicolaou, M. K. Nisar, H. Parfrey, E. R. Chilvers & A. J. K. Ostor. (2011) Non-infectious pulmonary toxicity of rituximab: a systematic review. Rheumatology 51:4, pages 653-662.
Crossref
Yoshikata Morita, Shogo Kuwagata, Noriko Kato, Yoshinori Tsujimura, Hiromi Mizutani, Mitsuhiro Suehiro & Motohide Isono. (2012) 18F-FDG PET/CT Useful for the Early Detection of Rapidly Progressive Fatal Interstitial Lung Disease in Dermatomyositis. Internal Medicine 51:12, pages 1613-1618.
Crossref
Yair Herishanu, Chava Perry & Aaron Polliack. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies 751 757 .
Bong-Il Song, Sang-Woo Lee, Hong Je Lee, Sungmin Kang, Shin Young Jeong, Ji-Hyoung Seo, Byeong-Cheol Ahn, Jaetae Lee & Kyung-Min Shin. (2010) Rituximab-Induced Pneumonitis on F-18 FDG PET/CT in Patient With Non-Hodgkin Lymphoma. Clinical Nuclear Medicine 35:8, pages 601-603.
Crossref
Larry C. Lands. (2010) New therapies, new concerns: rituximab-associated lung injury. Pediatric Nephrology 25:6, pages 1001-1003.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.